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An in-situ template fabrication of inorganic nanoparticles 
using carboxylated PEG-dendritic block copolymers of the 
GATG family is described as a function of the dendritic 
generation, the metal (Au, CdSe) and metal molar ratio. The 10 
biocompatibility of the generated nanoparticles analysed in 
terms of their aggregation in physiological media, cytotoxicity 
and uptake by macrophages relates to the PEG density of the 
surface of the hybrids. 
Introduction 15 
Hybrid organic-inorganic nanoparticles (NPs) are innovative 
nanomaterials that attract great attention due to their unique 
properties in scientific research and industry. By combining the 
functionality of inorganic particles and the flexibility of organic 
templates, hybrid materials are obtained with distinct 20 
physicochemical properties for applications in biotechnology,1 
memory devices,2 and sensors.3,4 Linear block copolymers are 
convenient organic matrices to template a variety of inorganic 
NPs with good control over size and particle size distribution.5, 6 
When appropriately designed, block copolymers result in phase-25 
separated nanodomains with different morphologies that can 
direct the assembly of metallic NPs into well-defined 
architectures with unique mechanical, optical, magnetic and 
electronic properties.7 Dendrimers have also received much 
attention as macromolecular hosts to template inorganic NPs by 30 
exploiting their characteristic highly functional surface and 
globular architecture in the nanometer scale.8-12 We envisaged 
that appropriately functionalized linear-dendritic copolymers13 
could bring together the favourable properties of dendrimers and 
block copolymers to template the fabrication of inorganic NPs 35 
and improve their colloidal stability and biocompatibility in 
physiological media. It has been reported that organosoluble 
linear-dendritic copolymers prepared by RAFT can disperse 
previously formed metallic NPs (TiO2, Au, CdSe) in organic 
solvents and a polymeric matrix.14 We hypothesised that the 40 
incorporation of the hydrophilic, FDA-approved poly(ethylene 
glycol) (PEG) as linear block could not only assist the template 
in-situ fabrication of NPs, but also enhance their aqueous 
solubility and stealth properties for biomedical applications. 
Thus, it is well known that the incorporation of PEG at the focal 45 
point of dendrimers results in customizable platforms where the 
careful selection of the PEG length, the nature of the peripheral 
groups, and the structure and generation of the dendritic block 
entail materials for specific applications in the biomedical field.15 
Indeed, polymeric micelles,16,17 hydrogels,18,19 and polymer–drug 50 
conjugates20,21 have been described from PEG-dendritic block 
copolymers for drug delivery, diagnosis, and tissue engineering. 
Herein we describe a straightforward in-situ route to generate 
biocompatible inorganic NPs templated by three generations (G1, 
G2, G3) of PEG-dendritic block copolymers of the GATG (gallic 55 
acid-triethylene glycol) family22 functionalized with peripheral 
carboxylate groups (Scheme 1). GATG dendrimers have recently 
emerged as a modular and versatile platform in the biomedical 
field with applications23,24,25 in drug and gene delivery,26,27,28,29 
diagnosis,30 antiviral agents,31 or for the treatment of 60 
neurodegenerative diseases.32 The presence of terminal azides on 
GATG facilitates their efficient decoration with a variety of 
ligands by means of the Cu(I)-catalyzed azide−alkyne 
cycloaddition (CuAAC).33,34,35, 36 The selection of carboxylates 
for the present purpose is based on their ability to complex metal 65 
ions and so direct the formation of hybrid dendritic materials. 
Two types of NPs have been prepared, namely noble metal Au 
and semiconductor CdSe. The potential of these NPs for 
biomedical applications has been preliminary assessed by 
studying their stability in serum, cytotoxicity, and phagocytosis 70 





Scheme 1. Schematic representation of the preparation 






Materials and Methods. CuSO4ꞏ5H2O and sodium bicarbonate 
were obtained from Prolabo. Sodium ascorbate was purchased 
from Acros Organics. 4-pentynoic acid and t-BuOH were 
obtained from Sigma-Aldrich. MeO-PEG5000-OH (Mn 5055.5, Mw 5 
5087.8 by MALDI-TOF) was purchased from Fluka. H2O was of 
Milli-Q grade. All other reagents were of analytical grade. 
Ultrafiltration was performed on stirred cells with Amicon® YM3 
membranes. NMR spectra were recorded on a Bruker DRX 500 
MHz. Chemical shifts are reported in ppm (δ units) downfield 10 
from internal HOD signal (D2O). FT-IR (KBr) spectra were 
recorded on a Bruker IFS-66v. Gel permeation chromatography 
(GPC) experiments were performed using a PSS Suprema Lux 
precolumn (10 µm, 8 x 50 mm) and a PSS Suprema Lux column 
(10 µm, 100 Å, 8 × 300 mm) with a UV detector (254 nm). A 10 15 
mM phosphate buffer pH 8.2 solution supplemented with 150 
mM LiCl was used as eluent at 1.0 mL/min. Solutions at 0.5-1.0 
mg/mL were filtered through 0.45 µm before injection. Dynamic 
light scattering (DLS) measurements were performed on a 
Malvern Nano ZS (Malvern Instruments) operating at 633 nm 20 
with a 173º scattering angle. Solutions at 1.0 mg/mL in 10 mM 
phosphate buffer pH 8.2 supplemented with 150 mM LiCl were 
filtered through 0.45 µm before analysis. UV-Vis spectra were 
recorded on a Varian Cary 50 and Varian Eclipse 
photospectrometer; the monochromator slit width was 5 nm. For 25 
TEM measurements, thin films of the solutions (0.3 mM) were 
spin-coated on carbon coated copper grids (400 mesh / AGAR 
Scientific) using a solid substrate support. The copper grid was 
then peeled of the substrate and analysed in a TECNAI BioTWIN 
(FEI Ltd.) transmission electron microscope at 100kV. The 30 
instrument was operated at low beam intensities to prevent 
electron damage of the polymer samples. HR-TEM 
measurements were performed using a JEOL JEM-2110F 
operated at 200kV; the instrument was equipped with an Orius 
SC1000 digital camera. The content of Au on macrophages was 35 
analysed by inductively coupled plasma mass spectrometry (ICP-
MS) on a Neptune MC-ICP-MS (Thermo Scientific). 
Synthesis of carboxylated PEG-dendritic block copolymers. 
PEG5000-[Gn]-N3 was dissolved in t-BuOH-H2O (1:1) at a final 
0.1 M concentration of terminal azides. Then, 4-pentynoic acid 40 
(200 mol% per N3), NaHCO3 (220 mol% per N3) and freshly 
prepared aqueous solutions of CuSO4 (5 mol% per N3) and 
sodium ascorbate (25 mol% per N3) were added. After 48 h of 
stirring at rt protected from light, reaction mixtures were purified 
by ultrafiltration (Amicon® YM3) washing with pH 2 aq HCl (2 x 45 
30 mL), sat NaHCO3 (2 x 30 mL), and H2O (4 x 30 mL) to afford 
PEG-[Gn]-CO2Na as white foams after freeze-drying. 
PEG-[G1]-CO2Na: PEG-[G1]-N3 (115 mg, 19.7 μmol), 4-
pentynoic acid (11.6 mg, 118 μmol), NaHCO3 (10.9 mg, 130 
μmol), sodium ascorbate (2.91 mg, 14.7 μmol), and CuSO4 (0.73 50 
mg, 2.95 μmol) were dissolved in t-BuOH (0.33 mL)-H2O (0.33 
mL), and following the general procedure described above, PEG-
[G1]-CO2Na (121 mg) was obtained in 99% yield. IR (KBr, cm-1) 
3426, 2887, 1666, 1581, 1115. 1H NMR (500 MHz, D2O) δ: 7.79 
(s, 1H), 7.78 (s, 2H), 7.18 (s, 2H), 4.59-4.49 (m, 6H), 4.30-4.12 55 
(m, 8H), 3.97-3.52 (m, 542 H), 3.41 (s, 3H), 3.28 (t, J = 4.89 Hz, 
2H), 2.94-2.84 (m, 6H), 2.54-2.44 (m, 6H). 13C NMR (75 MHz, 
D2O) δ: 181.9, 170.1, 162.3, 158.9, 152.5, 148.2, 140.3, 129.7, 
123.8, 106.9, 72.7, 71.6, 71.2, 70.7, 70.3, 70.1, 70.0, 69.9, 69.7, 
69.5, 69.4, 69.1, 69.0, 58.6, 50.4, 40.6, 40.0, 37.4, 22.3. 60 
PEG-[G2]-CO2Na: PEG-[G2]-N3 (111 mg, 14.5 μmol), 4-
pentynoic acid (25.7 mg, 263 μmol), NaHCO3 (24.1 mg, 280 
μmol), sodium ascorbate (6.45 mg, 32.6 μmol), and CuSO4 (1.63 
mg, 6.50 μmol) were dissolved in t-BuOH (0.66 mL)-H2O (0.66 
mL), and following the general procedure described above, PEG-65 
[G2]-CO2Na (113 mg) was obtained in 90% yield. IR (KBr, cm-1) 
3408, 2887, 1650, 1581, 1114. 1H NMR (500 MHz, D2O) δ: 7.78 
(s, 3H), 7.76 (s, 6H), 7.15-7.03 (m, 8H), 4.52 (br s, 18H), 4.20-
4.02 (m, 20H), 3.99-3.51 (m, 693 H), 3.41 (s, 3H), 3.20 (br s, 
2H), 2.94-2.83 (m, 18H), 2.54-2.44 (m, 18H). 13C NMR (75 70 
MHz, D2O) δ: 181.5, 168.8, 151.9, 147.7, 139.8, 129.8, 123.5, 
106.2, 72.0, 70.9, 70.6, 69.4, 69.0, 68.7, 68.4, 68.2, 58.1, 49.7, 
39.5, 36.7, 21.7. 
PEG-[G3]-CO2Na: PEG-[G3]-N3 (78 mg, 6.0 μmol), 4-pentynoic 
acid (32.0 mg, 326 μmol), NaHCO3 (30.2 mg, 359 μmol), sodium 75 
ascorbate (8.08 mg, 40.8 μmol), and CuSO4 (2.00 mg, 8.20 μmol) 
were dissolved in t-BuOH (0.82 mL)-H2O (0.82 mL), and 
following the general procedure described above, PEG-[G3]-
CO2Na (98 mg) was obtained in 99% yield. IR (KBr, cm-1) 3400, 
2876, 1646, 1581, 1114. 1H NMR (500 MHz, D2O) δ: 7.87-7.65 80 
(m, 27H), 7.09 (s, 26H), 4.62-4.40 (m, 54H), 4.32-3.99 (m, 80H), 
3.97-3.46 (m, ~966H), 3.41 (m, 5H), 2.97-2.77 (m, 54H), 2.59-
2.35 (m, 54H). 
Nanoparticle Preparation. Carboxylated PEG-[Gn]-CO2Na 
copolymers were used to prepare metallic Au and semiconductor 85 
CdSe NPs. Firstly, PEG-[Gn]-CO2Na of G1, G2, and G3 were 
dissolved in aqueous media at a concentration of 0.3 mM. 
For the preparation of Au NPs, an Au precursor (HAuCl4) was 
added to the polymer solutions at molar ratios 1:1 and 3:1 with 
respect to the number of carboxylate end-groups. HAuCl4 was 90 
then reduced to metallic Au0 using a three-fold molar excess of 
aqueous 0.1 M NaBH4. Upon addition of the reducing agent, the 
solutions turned ruby red indicating the formation of Au NPs. 
For the preparation of CdSe NPs, firstly, Cd(OAc)2 was added to 
the copolymer solutions in molar ratios 1:1 and 3:1 with respect 95 
to the number of carboxylate end-groups. Then, a fresh solution 
of 5 mM NaHSe in anhydrous EtOH was prepared by reaction of 
Se powder with NaBH4 under inert atmosphere. CdSe NPs were 
formed upon injecting the NaHSe solution into the aqueous 
solution containing Cd(II) under inert atmosphere and vigorous 100 
stirring. The solutions turned brightly yellow-orange indicating 
the formation of semiconductor CdSe nanoclusters. 
Aggregation studies. 50 µg/mL of NPs in RPMI with 10% fetal 
calf serum (FCS) were incubated overnight at 37 ºC and the 
formation of aggregates was evaluated in an optical inverted 105 
microscope (model IX50 Olympus Optical Co, GMBH, 
Germany). Amplification: 40x objective. 
Cellullar experiments. For toxicology analysis, the human 
tumour cell lines Hmy2 and U937 were used, which correspond 
to lymphoblastoid B and myeloid-monocytic lymphoma (myeloid 110 
origin) cell lines, respectively. All cells were maintained in RPMI 
(Gibco, Life Technologies, Grand Island) supplemented with 10 
wt. % heat inactivated FCS (PAA, Linz, Austria), penicillin (100 
U/mL), streptomycin (100 μg/mL) and glutamine (2 mM) (Gibco) 
at 37 ºC in a humidified atmosphere containing 5 vol % CO2. 115 
Mouse peritoneal macrophages were collected by flushing with 
PBS the peritoneal cavity of C57BL6 mice. Recovered cells were 
centrifuged for 5 min at 231 g and resuspended in RPMI 
containing 10% heat inactivated FCS. 
Cellular proliferation colorimetric assay. Previous to perform 
the viability assays, the optimal cell number per well (from 5.000 5 
up to 35.000 cells) was determined at 24 and 48 h. The number of 
cells in which the absorbance reached an exponential growing of 
cells, was considered optimal. Cells were treated with the Quick 
Cell proliferation testing solution (GenScript Corporation, 
Piscataway, NJ, USA), following manufacturer instructions. 10 
Briefly, after incubation, plates were centrifuged at 1000 g for 1 
min, 100 µL of the supernatant were discarded and 50 µL of 
Quick Cell reagent added. Then, plates were incubated for 3 h at 
37 ºC, centrifuged again and supernatants were transferred to 
clean plates. All assays were performed twice for each cell line, at 15 
24 and 48 h, and in triplicate for each NPs concentration. The 
absorbance was measured at 450 nm in a microplate reader 
(MULTISKAN EX. BioAnalysisLabsystems). For viability 
assays, cells were incubated in the presence of 0.5 µg/mL or 50 
µg/mL of NPs for 24 and 48h, and the viability was analyzed 20 






Phagocytosis studies using mouse macrophages. The protocol 
was adapted to the guidelines of the Spanish regulations (Royal 
Decree 53/2013) regarding the use of animals in scientific 25 
research and under the approval of the ethical committee of the 
University of Vigo (Spain) (number 03/11). Peritoneal 
macrophages were plated in 24-well plates (Becton Dickinson, 
Franklin Lakes, USA). After 1 h of incubation at 37 ºC in a 
humidified atmosphere, hybrid NPs were added to the cells and 30 
incubated overnight at 37 ºC with 5 vol % CO2. Macrophages 
were washed several times with PBS and then 100 μL of H2O 
were added to kill the cells. Cell lysates in H2O were collected for 
ICP-MS assay and the concentration of phagocyted Au (per 100 
g/mL of hybrids) was measured. 35 
Results and discussion 
Three generations of PEG-GATG copolymers carrying 3, 9, and 
27 carboxylate groups (PEG-[Gn]-CO2Na, n=1,2,3) where readily 
prepared by CuAAC from the corresponding PEG-[Gn]-N3 (90-
99% yield, PEG5000, Figure S1 in the ESI).29,37 Complete 40 
functionalization of the copolymers was demonstrated by IR 
(disappearance of the intense characteristic azide signal at 2107 
cm-1) and 1H NMR (D2O, appearance of two singlets at ca. 7.8 
ppm in a ratio 1:2 corresponding to the triazol protons and a 
multiplet around 4.5 ppm characteristic of the methylene protons 45 
adjacent to the triazol ring). Gel permeation chromatography 
(GPC) confirmed the integrity and purity of the products, in 
addition to the expected increase in size with generation (Figure 
1). These materials showed complete aqueous solubility. As seen 
in Figures 1 and S2, no sign of aggregation was observed by 50 
dynamic light scattering (DLS) which in agreement with GPC 
revealed an increase in mean hydrodynamic diameter on going 
from G1 (4.6 nm) to G2 (5.4 nm) and G3 (6.8 nm). Because of 
their high solubility and the absence of aggregation, PEG-[Gn]-
CO2Na were readily used for the preparation of NPs, namely Au 55 
and CdSe. These NPs have recently attracted much attention in 
the biomedical field due to their optical and luminescence 
properties with interesting applications in drug and gene delivery, 
hyperthermia treatment and tumour ablation in cancer therapy.38 
 60 
Figure 1. DLS size distribution and normalized GPC 
elugrams of PEG-[Gn]-CO2Na (10 mM phosphate buffer pH 
8.2, 150 mM LiCl). 
 
Templated preparation of hybrid PEG-GATG – Au NPs. Au 65 
NPs were synthesized in a two-step process comprising extraction 
of aqueous AuCl4- into the carboxylated GATG block, followed 
by reduction with NaBH4. The efficiency of PEG-GATG to 
template NPs by this in-situ approach was evaluated by UV–vis 
and transmission electron microscopy (TEM). Both 70 
measurements were conducted for G1-G3 using molar ratios 1:1 
and 1:3 between the carboxylate groups on the dendritic block 
and the inorganic HAuCl4 precursor. Figure 2 shows typical UV–
vis spectra of Au NPs (50 g/mL) prepared within the PEG-
GATG matrix. The plasmon peak at around 525 nm observed for 75 
all samples is attributed to collective oscillation of free electrons 
in Au NPs.39 The gradual increase of absorption below 400 nm is 
due to the inter-band transition of Au. The absorbance peak at 
285 nm for all NPs is assigned to the characteristic ion-pair 
formation between AuCl4- and the PEG-dendritic copolymers 80 
after adding the Au-precursor.9, 40 
 
 
Figure 2. UV-vis spectra of PEG-GATG – Au NPs showing 
a plasmon band at 525 nm and a shoulder at 285 nm. 
 
TEM micrographs in Figure 3 show Au NPs (ratio 1:1) with 5 
average size in the range 4-10 nm. NPs templated within G1 
reveal irregular shape and average size 8±1.5 nm. On increasing 
the dendrimer generation, the templating effect of the dendritic 
block becomes dominant, resulting in average sizes 6±1.2 and 
4±1 nm for G2 and G3, respectively. It is proposed that the larger 10 
G1 NPs are produced by overlapping of two or more smaller 
particles that in the two-dimensional HRTEM projection appear 
as a single one (Figure S3). It seems that in G1, the generated Au 
NPs are partially coated with dendritic wedges which lead to a 
high surface energy and aggregation to form larger particles. The 15 
use of the G2 and G3 copolymers results in an enhanced control 
over the particle growth and smaller NPs. This is attributed to a 
more effective passivation of the generated NPs within the 
dendritic matrices, a mechanism contributing to avoid 
flocculation probably via steric stabilisation.41 20 
 
Figure 3. TEM of Au NPs templated by carboxylated PEG-
GATG. (a) PEG-[G1]-Au (1:1), (b) PEG-[G2]-Au (1:1), (c) 
PEG-[G3]-Au (1:1). 
 25 
PEG-GATG templates CdSe NPs. CdSe NPs were prepared by 
injection of NaHSe to carboxylated PEG-GATG previously 
complexed with Cd(OAc)2 in aqueous solution. Cd(OAc)2 was 
added to G1-G3 copolymers in molar ratios carboxylate to Cd, 
1.1 and 1:3. Figure 4 displays photoluminescence emission 30 
spectra of CdSe NPs (excitation at 360 and 380 nm) showing 
emissions with maxima at 480 and 510 nm, respectively, which 
correspond to electron-hole radiative recombination from trap 
states. The peak of NPs templated within G3 at 480 nm is narrow 
and of high intensity, reflecting CdSe NPs with low 35 
polydispersity. The peaks around 510 nm for G1 and G2 are 
wider than G3, refereeing to larger NPs and higher dispersity.12, 
42, 43 These results point again to a generation dependent 
stabilisation mechanism of NPs in the template process also 
confirmed by TEM. 40 
 
 
Figure 4. Photoluminescence spectra of CdSe NPs 
templated within carboxylated PEG-GATG copolymers. 
 45 
TEM micrographs of the NPs are shown in Figure 5. Particles 
stabilised within G1 possess not uniform morphologies with 
average size 8±1.5 nm. As previously observed for Au, CdSe NPs 
stabilised by G2 and G3 markedly revealed smaller in size 
(5±0.1nm), consistent again with the existence of a generation 50 
dependent mechanisms to template the NPs. In the case of the 
smaller particles, PEG-GATG acts as a nanoreactor controlling 
the growth of the CdSe NPs within defined dendritic cavities. On 
the contrary, the alignment of the smaller G1 wedges on the NP 
surface results in a lower control over size.44 55 
 
 
Figure 5. TEM of (a) PEG-[G1]-CdSe (1:3), (b) PEG-[G2]-
CdSe (1:3), (c) PEG-[G3]-CdSe (1:3). 
 
Aggregation in physiological media depends on the dendritic 5 
block generation. Since nanostructures for in vivo applications 
should be biocompatible and not aggregate in the presence of 
serum proteins, we decided to analyse the behaviour of the NPs in 
physiological media. Accordingly, all NPs were incubated in the 
presence of media supplemented with fetal calf serum (FCS) at 10 
37 ºC with 5% of CO2. As seen in Table 1 and Figures 6 and S4, 
optical microscopy showed the presence of aggregates at higher 
dendrimer G and on increasing the carboxylate:metal molar ratio 
from 1:1 to 1:3. The increased aggregation observed at higher G 
can be explained by the lower PEG density on the surface of 15 
these hybrids. Indeed, the architecture of dendronized Au and 
CdSe NPs has been claimed as controlled by a sterically induced 
stoichiometry,45 where the relative size between the metal core 
and the dendrimers on the shell determines the core-shell 
stoichiometry by steric reasons.46,47 In this scenario, an increased 20 
number of PEG-dendritic copolymers of lower G is expected to 
accommodate around the metal core, resulting in a higher PEG 
density and enhanced stability towards aggregation with serum 
proteins. This situation is similar to that seen in PEG-GATG–
based dendriplexes previously described by our group (a pDNA 25 
core surrounded by a shell of dendrimers) where the lower G 
copolymers afford a more effective shielding of the surface 
charge because of a denser PEG palisade.27, 28 The lower PEG 
content also explains the larger aggregation seen on increasing 
the carboxylate:metal molar ratio. 30 
 
Table 1: Aggregation of metal NPs in the presence of serum analyzed by 
optical microscopy (50 μg/mL of NPs in RPMI supplemented with 10% 
FCS) 






PEG-[G1]-Au (1:1) − 
PEG-[G1]-Au (1:3) ± 
PEG-[G2]-Au (1:1) + 
PEG-[G2]-Au (1:3) ++ 
PEG-[G3]-Au (1:1) + 






PEG-[G1]-CdSe (1:1) + 
PEG-[G1]-CdSe (1:3) ++ 
PEG-[G2]-CdSe (1:1) + 
PEG-[G2]-CdSe (1:3) ++ 
PEG-[G3]-CdSe (1:1) + 
PEG-[G3]-CdSe (1:3) ++ 
++, +, ±, − refer to high, medium, low, and no aggregation. 35 
 
 
Figure 6. Aggregation of Au NPs in the presence of serum 
by optical microscopy (40x objective). 
NPs display low toxicity. The biocompatibility of the less 40 
aggregating NPs was further assessed in cell toxicity experiments 
at 24 and 48 h with no statistical differences between them. Thus, 
PEG-[G1,2,3]-Au (1:1), PEG-[G1]-Au (1:3) and PEG-[G1,2,3]-
CdSe (1:1) hybrids were tested in Hmy2 (Figure 7) and U937 
(not shown) cell lines. The toxicity of the three generation block 45 
copolymers was also studied, revealing non-toxicity after 48 h of 
incubation with the cells (Figure S5). Following the 
Nanotechnology Characterization Laboratory criteria regarding 
toxicity48 (cell viability higher than 75% at 48 h), it can be 
concluded that the tested Au NPs showed null or very low 50 
cytotoxicity on human cells (Figure 7). This result is in 
agreement with previous reports from several groups,49 including 
ours,50 on the relative lack of toxicity of conventional Au NPs. It 
was also interesting to see the good viability results obtained with 
PEG-[G1]-CdSe (1:1) considering the high toxicity traditionally 55 
associated to CdSe systems.51, 52 On increasing G, however, 
toxicity was induced in CdSe NPs at the highest concentration 
tested (50 g/mL), a result confirming again the higher 
biocompatibility of the lower G hybrids as a result of their 
increased PEG content. 60 
 
Figure 7. Cell viability of the Hmy2 cell line at 48 h in the 
presence of several NPs. 
 
Phagocytosis. Innate immune cells such as macrophages are very 5 
active cells in the uptake and quick removal of nanostructures 
from circulation.53, 54 For instance, in the case of Au, it is known 
that the scavenger receptor A mediates the uptake of Au colloids 
by macrophages.55 PEGylation has been proposed as an effective 
way to grant nanostructures with stealth properties and hence, 10 
prolong their circulation times.56, 57 In order to further asses the 
behaviour of the sterically stabilized hybrids herein reported in 
the presence of phagocytic cells, we have studied the uptake of 
the PEG-[G1,2,3]-Au (1:1) structures in normal peritoneal mouse 
macrophages. Thus, the hybrids were added on top of cells, and 15 
after incubation and several washes, the amount of Au was 
analysed by ICP-MS in the cell lysates. The results show in all 
cases very low concentration of Au inside the cells, in agreement 
with the hybrids being not highly internalized (Figure 8). 
Relatively higher capture efficiency was however observed for 20 
PEG-[G2]-Au and PEG-[G3]-Au. Although it is not possible to 
exclude this higher uptake as related to properties like the size or 
aggregation of these hybrids in physiological media, it cannot be 
ignored its close correlation with their lower density of PEG 
compared to G1, a result that stresses again the reduction of cell 25 
uptake and potential toxic effects imparted by PEG to 
nanomaterials.58, 59 
 
Figure 8. Phagocytosis of Au NPs by macrophages 
determined by ICP-MS in cell lysates. 30 
Conclusions 
Three generations of PEG-dendritic block copolymers of the 
GATG family functionalized with peripheral carboxylates have 
been used to template different types of inorganic (Au and CdSe) 
NPs by an in-situ reduction approach. A generation dependent 35 
template mechanism was confirmed that results in an enhanced 
control over the particle growth and smaller sizes on increasing 
the dendritic generation (G). On the other hand, the higher 
biocompatibility of the lower G hybrids is interpreted as a result 
of the characteristic architecture of these metallic NPs controlled 40 
by a sterically induced stoichiometry. The presence of a single 
PEG chain in the block copolymers (irrespective of G) ensues a 
denser PEG palisade around the metal core for the lower G 
hybrids, that finally leads to a reduced aggregation in 
physiological media, cytotoxicity and uptake by macrophages. 45 
Based on these results, the incorporation of higher molecular 
weight PEG chains is envisioned as a prospective way to grant 
these hybrids with enhanced steric stabilization. 
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